In the News
Federal Officials Investigate Online Ketamine Sellers to Curb At-Home Use
The federal government is cracking down on online ketamine sellers amid growing concerns about misuse, adverse effects, and deaths from at-home use. The DEA has multiple ongoing investigations into “bad actors” prescribing the powerful mind-altering drug online, while the FDA recently sent warning letters to 14 online marketers—including ketaminetroches.com and legitketaminesuppliers.com—ordering them to stop selling unapproved ketamine products. The moves target an industry many have called a “Wild West,” with hundreds of businesses selling vials, powders, nasal sprays, and lozenges to consumers, often without proper medical supervision. The action follows a March 2026 WSJ report revealing that ketamine use has skyrocketed under loosened pandemic-era telehealth rules, which currently allow clinicians to prescribe controlled substances remotely without an in-person visit—a flexibility set to expire at the end of 2026.
Hip Replacement Lawsuits Grow as Defective Metal Implants Pay Over $65 Billion to Thousands of Patients by Diane Lilli | Mar 24, 2021
James A. Morris, Jr. was recently featured in an article discussing the current state of lawsuits filed against makers of defective metal hip replacements. Mr. Morris was interviewed regarding the harm from a defective implant that could give rise to a lawsuit and what affected individuals should do to protect their rights.
